Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Free Cash Flow Generation Index
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Free Cash Flow Generation Index of 0.72x as of December 2024. Free cash flow of CN¥83.22 Million represents 1% of operating cash flow (CN¥116.38 Million). See Medprin Regenerative Medical Technologie (301033) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Medprin Regenerative Medical Technologies Co. Ltd. Free Cash Flow Generation Index (2019–2024)
Historical FCF Generation Index trend for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. Explore how well can Medprin Regenerative Medical Technologie service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year Free Cash Flow Generation Index for Medprin Regenerative Medical Technologies Co. Ltd.. For the full company profile including market capitalisation, see Medprin Regenerative Medical Technologie market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.72x | CN¥83.22 Million | CN¥116.38 Million | CN¥33.16 Million | ▲ +13.9% |
| 2023 | 0.63x | CN¥67.60 Million | CN¥107.69 Million | CN¥40.09 Million | ▲ +134.6% |
| 2022 | -1.81x | CN¥-87.65 Million | CN¥48.31 Million | CN¥135.96 Million | ▼ -40.0% |
| 2021 | -1.30x | CN¥-86.20 Million | CN¥66.51 Million | CN¥152.71 Million | ▼ -58.4% |
| 2020 | -0.82x | CN¥-27.74 Million | CN¥33.91 Million | CN¥61.65 Million | ▼ -370.6% |
| 2019 | -0.17x | CN¥-5.44 Million | CN¥31.27 Million | CN¥36.71 Million | — |